What is the prevalence of Parkinson’s disease in Asia?

The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease. The creator of this program has divided into four segments to cover a complete plan to treat this disease along with improving your health and life by knowing everything about this health problem. The main focus of this program is on boosting the levels of hormone in your brain by making e a few easy changes in your lifestyle, diet, and thoughts

What is the prevalence of Parkinson’s disease in Asia?

The prevalence of Parkinson’s disease in Asia varies widely across countries due to differences in population size, age distribution, genetics, and healthcare infrastructure. However, like in Europe, the prevalence is increasing across the region due to aging populations. Here’s a breakdown of the key factors regarding Parkinson’s prevalence in Asia:

General Prevalence

Overall Prevalence: The prevalence of Parkinson’s disease in Asia ranges from 50 to 200 cases per 100,000 people, depending on the country. This range is lower than in Europe and North America, though the numbers are rising.
Age-Specific Prevalence: As in other parts of the world, Parkinson’s disease primarily affects older individuals. Among people over 60, prevalence rates are often around 1%, similar to global estimates. In some Asian countries, the prevalence in those over 80 can reach 3-4%.

Country-Specific Data

China: China, with the world’s largest aging population, has a Parkinson’s prevalence of around 170 to 200 per 100,000 people in the general population. With its rapidly aging population, China is expected to see a significant increase in the number of Parkinson’s cases in the coming decades.
India: India reports a lower prevalence of around 70 to 150 per 100,000 people, but like China, the number of Parkinson’s cases is expected to rise as the population ages. In urban areas, the rates may be higher due to better diagnostic capabilities.
Japan and South Korea: Japan has a relatively high prevalence of Parkinson’s disease, with estimates ranging from 100 to 200 per 100,000 people, due to its older population. South Korea shows similar trends, with a prevalence rate of around 150 to 200 per 100,000 people.
Southeast Asia (e.g., Thailand, Malaysia): Countries in Southeast Asia typically have lower reported prevalence rates, around 50 to 100 per 100,000, though these numbers may be underestimated due to limited access to neurological care in rural areas.

Factors Influencing Prevalence

Aging Population: Many Asian countries, particularly in East Asia (China, Japan, South Korea), are experiencing a rapid increase in the elderly population. This demographic shift is contributing to a rising prevalence of Parkinson’s disease.
Environmental and Genetic Factors: Studies suggest that environmental factors such as pesticide exposure and diet may influence Parkinson’s risk in Asia. Additionally, genetic factors could play a role, with certain mutations (such as in the LRRK2 gene) being more common in Asian populations.

Regional Variations

Urban vs. Rural Disparities: Urban areas tend to report higher prevalence rates due to better access to healthcare and more accurate diagnosis. In rural areas, the prevalence may be underreported due to lack of access to neurological specialists and diagnostic tools.
Healthcare Infrastructure: Countries with more developed healthcare systems, like Japan and South Korea, tend to have more accurate data on Parkinson’s prevalence, while countries with less developed infrastructure may underreport cases.

Future Trends

Rising Prevalence: The prevalence of Parkinson’s disease in Asia is expected to increase significantly over the next few decades due to population aging. For example, in China alone, the number of Parkinson’s cases is projected to double or triple by 2050.
Increased Awareness and Diagnosis: As awareness of Parkinson’s disease grows and diagnostic capabilities improve, more cases are likely to be identified, particularly in countries like India, Indonesia, and Vietnam, where neurological care is expanding.

Conclusion:

The prevalence of Parkinson’s disease in Asia is currently estimated at 50 to 200 per 100,000 people, with significant variability across countries. The prevalence is expected to rise substantially due to the aging population and improved diagnostic capabilities. Urban-rural disparities and differences in healthcare access also contribute to variability in reporting across the region.

Jodi Knapp